Open AccessThe treatment of hypertension by labetalol‐a new alpha‐ and beta‐adrenoreceptor blocking agent
Author(s) -
Stern N.,
Teicher A.,
Rosenthal T.
Publication year - 1982
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960050202
Subject(s) - labetalol , medicine , alpha (finance) , beta (programming language) , blocking (statistics) , pharmacology , adrenergic beta antagonists , blood pressure , surgery , propranolol , mathematics , construct validity , statistics , computer science , patient satisfaction , programming language
Summary: A new alpha‐ and beta‐blocking agent, labetalol, was used to treat 50 hypertensive patients, 34 of them with refractory hypertension. A significant reduction in hypertension was achieved with relatively few adverse reactions. The combination of alpha and beta blockers in labetalol with their mutually opposing characteristics offers an interesting and promising approach to the control of hypertension.